Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
{ "products": [ { "_id": "6660456866170d1ff8cb29b0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "sitagliptin phosphate and metformin hydrochloride tablets", "description": "GLISITAPTIN M KIT \nCombipack of sitagliptin phosphate (100mg) & Metformin HCI SR (1000mg)\nIntroduction to GLISITAPTIN M KIT\nGLISITAPTIN M KIT is a combination pack that includes Sitagliptin Phosphate 100mg and Metformin HCl SR 1000mg. This combipack is designed for the comprehensive management of type 2 diabetes mellitus. By combining the complementary mechanisms of Sitagliptin and Metformin, GLISITAPTIN M KIT provides effective glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Sitagliptin and Metformin?\nOverview of Sitagliptin\nSitagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that enhances the body's natural incretin hormones, which help regulate blood glucose by increasing insulin release and decreasing glucagon levels in response to meals.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release (SR) formulation ensures a prolonged effect throughout the day.\n\nBenefits of GLISITAPTIN M KIT\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Sitagliptin helps regulate postprandial (after-meal) glucose levels, while Metformin assists in lowering fasting glucose levels by promoting insulin sensitivity and reducing hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: GLISITAPTIN M KIT is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, this combination medication can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nConvenience and Compliance\nTwice-Daily Dosing: The sustained-release formulation of Metformin allows for effective blood sugar control with twice-daily dosing, improving patient compliance.\nReduced Pill Burden: Combining two effective diabetes medications into a single combipack simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy.\nHow to Use GLISITAPTIN M KIT\nDosage and Administration\nRecommended Dosage: The typical dosage of GLISITAPTIN M KIT is one tablet of Sitagliptin 100mg taken once daily and one tablet of Metformin HCl SR 1000mg taken twice daily, with meals. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablets with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablets whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take GLISITAPTIN M KIT regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glisitaptin-m-kit-133870", "price": 520.0, "discountamount": 156.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Diet", "Order", "EMAIL", "meals", "liver", "water", "amount", "action", "Support", "tablets", "patients", "Overview", "Benefits", "readings", "biguanide", "neuropathy", "one tablet", "Guidelines", "full glass", "retinopathy", "information", "Optimal Use", "Convenience", "utilization", "Adjustments", "best results", "Postprandial", "sterispharma", "Introduction", "Reduced Risk", "sterisonline", "blood glucose", "CALL/WHATSAPP", "effectiveness", "Administration", "typical dosage", "Consistent Use", "dual mechanism", "treatment plan", "glucagon levels", "two medications", "insulin release", "Metformin HCl SR", "Metformin HCI SR", "Exercise Adjunct", "prolonged effect", "combination pack", "single combipack", "Sitagliptin 100mg", "multiple pathways", "excellent adjunct", "GLISITAPTIN M KIT", "treatment regimen", "glucose regulation", "Twice-Daily Dosing", "patient compliance", "Recommended Dosage", "prescribed therapy", "Reduced Pill Burden", "insulin sensitivity", "individual response", "healthcare provider", "Diabetes Management", "meal) glucose levels", "sitagliptin phosphate", "cardiovascular disease", "combination medication", "long-term complications", "lifestyle modifications", "Fasting Glucose Control", "comprehensive management", "type 2 diabetes mellitus", "complementary mechanisms", "natural incretin hormones", "stable blood sugar levels", "peripheral glucose uptake", "hepatic glucose production", "effective glycemic control", "gastrointestinal discomfort", "sustained-release formulation", "effective blood sugar control", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitor", "two effective diabetes medications", "sustained-release (SR) formulation", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1373, "imageuri": "https://productimages.withfloats.com/actual/6660456a9a0a3c2c06ff4c20.png", "tileimageuri": "https://productimages.withfloats.com/tile/6660456a9a0a3c2c06ff4c20.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:00:56.265Z", "updatedon": "2026-03-13T06:01:47.78Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-phosphate-and-metformin-hydrochloride-tablets/1373", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLISITAPTIN M KIT ", "category": "DIABETIC RANGE", "tags": [ "GLISITAPTIN M KIT", "Combipack of sitagliptin phosphate (100mg)", "Metformin HCI SR (1000mg)", "Metformin SR 1000 mg uses", "Metformin SR 1000 mg side effects", "Metformin SR 1000 Mg Uses in Hindi", "Metformin SR 1000 mg price in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6979b09d927481ba212bc573", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tedizolid Phosphate 200 mg ", "description": "TEDIZOLINE 200 is a state-of-the-art pharmaceutical formulation containing Tedizolid Phosphate 200 mg, representing a significant advancement in the treatment of serious bacterial skin infections. This next-generation oxazolidinone antibiotic offers a powerful solution for patients battling acute bacterial skin and skin structure infections (ABSSSI), including those caused by methicillin-resistant Staphylococcus aureus (MRSA) and other resistant bacterial strains. Developed to address the growing challenge of antibiotic resistance, TEDIZOLINE 200 provides healthcare professionals with an effective therapeutic option when conventional antibiotics may fall short.\nThe active ingredient, Tedizolid Phosphate, functions as a prodrug that is rapidly converted in the body to its active form, tedizolid. This sophisticated mechanism ensures optimal bioavailability and targeted antibacterial action. Each tablet of TEDIZOLINE 200 delivers a precise 200 mg dose, carefully calibrated to provide maximum efficacy while minimizing the risk of adverse effects. The medication is available in convenient oral tablet form, offering flexibility in treatment administration and improving patient compliance compared to intravenous-only alternatives.\nClinical Applications and Therapeutic Uses\nTEDIZOLINE 200 is specifically indicated for the treatment of acute bacterial skin and skin structure infections caused by susceptible strains of various gram-positive bacteria. These infections include cellulitis, major cutaneous abscesses, and wound infections that require systemic antibiotic therapy. The medication demonstrates exceptional efficacy against problematic pathogens including Staphylococcus aureus (both methicillin-susceptible and methicillin-resistant strains), various Streptococcus species, and Enterococcus faecalis.\nHealthcare providers prescribe TEDIZOLINE 200 when patients present with complicated skin infections characterized by significant inflammation, purulent discharge, or systemic signs of infection such as fever and elevated white blood cell counts. The medication is particularly valuable in hospital settings where antibiotic-resistant organisms pose significant treatment challenges, though it is equally effective for outpatient management of appropriate cases.\nThe standard treatment duration with TEDIZOLINE 200 is notably shorter than many traditional antibiotics, typically requiring only six days of therapy. This abbreviated course represents a significant advantage, potentially improving patient adherence, reducing the risk of developing resistance, and minimizing healthcare costs while maintaining excellent clinical outcomes.\nKey Benefits and Therapeutic Advantages\nSuperior Antimicrobial Potency: TEDIZOLINE 200 exhibits exceptional bactericidal activity against resistant gram-positive organisms, making it a frontline weapon against infections that have failed to respond to first-line antibiotics. Its unique mechanism of action—inhibiting bacterial protein synthesis by binding to the 23S ribosomal RNA of the 50S subunit—prevents bacteria from producing essential proteins necessary for survival and reproduction.\nShortened Treatment Duration: Unlike conventional antibiotics that may require ten to fourteen days of therapy, TEDIZOLINE 200 achieves comparable or superior outcomes with just six days of treatment. This condensed regimen reduces the pill burden for patients, improves treatment completion rates, and decreases the opportunity for resistance development.\nFlexible Administration Options: The medication offers both oral and intravenous formulations with nearly identical bioavailability, allowing seamless transitions between routes of administration. This flexibility enables early hospital discharge with continuation of oral therapy at home, reducing healthcare costs and improving patient comfort and quality of life.\nOnce-Daily Dosing Convenience: TEDIZOLINE 200's pharmacokinetic profile supports convenient once-daily administration, simplifying treatment schedules and enhancing patient compliance. The sustained therapeutic levels achieved with this dosing frequency ensure continuous antibacterial activity throughout the treatment course.\nReduced Drug Interaction Profile: Compared to its predecessor oxazolidinone antibiotics, TEDIZOLINE 200 demonstrates minimal interactions with dietary tyramine and requires less stringent dietary restrictions. Additionally, it exhibits reduced potential for serotonin syndrome, offering improved safety when used in patients taking certain antidepressants or other serotonergic medications.\nProven Clinical Efficacy: Extensive clinical trials have demonstrated that TEDIZOLINE 200 achieves cure rates comparable to or exceeding those of vancomycin and linezolid, the traditional gold standards for treating MRSA infections. These studies confirm both the non-inferiority and, in some parameters, the superiority of tedizolid phosphate in treating complicated skin infections.\nPotential Side Effects and Safety Considerations\nWhile TEDIZOLINE 200 is generally well-tolerated, patients and healthcare providers should be aware of potential adverse effects. The most commonly reported side effects include nausea, headache, diarrhea, and vomiting, which typically manifest as mild to moderate in severity and often resolve without intervention.\nGastrointestinal disturbances affect approximately five to ten percent of patients, with nausea being the most frequent complaint. Taking the medication with food may help minimize these symptoms without compromising absorption. Headaches occur in a similar percentage of patients and usually respond well to over-the-counter analgesics.\nMore serious but less common adverse effects include myelosuppression, manifesting as decreased blood cell counts. Although TEDIZOLINE 200 demonstrates less bone marrow suppression than older oxazolidinones, monitoring of complete blood counts is recommended for treatment courses extending beyond the standard six days or in patients with pre-existing hematologic conditions.\nPeripheral and optic neuropathy have been reported with prolonged oxazolidinone use, though the shorter treatment duration of TEDIZOLINE 200 substantially reduces this risk. Patients should report any vision changes, numbness, tingling, or weakness in extremities promptly to their healthcare provider.\nClostridium difficile-associated diarrhea can occur with virtually any antibiotic, including TEDIZOLINE 200. Patients experiencing severe, persistent, or bloody diarrhea during or following treatment should seek immediate medical attention.\nHypersensitivity reactions, though rare, may occur and can range from mild rash to severe anaphylaxis. Any signs of allergic reaction warrant immediate discontinuation and appropriate medical intervention.\nConclusion\nTEDIZOLINE 200 represents a significant therapeutic advancement in the management of acute bacterial skin and skin structure infections, particularly those involving antibiotic-resistant organisms. Its potent antimicrobial activity, convenient once-daily dosing, shortened treatment duration, and improved safety profile compared to earlier oxazolidinones make it an invaluable addition to the antimicrobial arsenal. The medication addresses critical unmet needs in infectious disease management, offering effective treatment options when traditional antibiotics prove insufficient.", "price": 1250.0, "discountamount": 375.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2288, "imageuri": "https://productimages.withfloats.com/actual/6979b0c4b75d7c0b79b08e15.png", "tileimageuri": "https://productimages.withfloats.com/tile/6979b0c4b75d7c0b79b08e15.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-28T06:45:49.837Z", "updatedon": "2026-04-17T11:40:48.569Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//tedizolid-phosphate-200-mg-/2288", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TEDIZOLINE 200", "category": "DERMATALOGY", "tags": [ "tedizolid phosphate 200 mg tablet", "tedizolid phosphate 200 mg uses", "tedizolid phosphate 200 mg dosage", "tedizolid phosphate tablets 200 mg price", "tedizolid phosphate 200 mg side effects", "tedizolid phosphate 200 mg brand name", "tedizolid phosphate 200 mg mechanism of action", "buy tedizolid phosphate 200 mg tablet", "tedizolid phosphate 200 mg prescription info", "tedizolid phosphate 200 mg tablet details", "tedizolid phosphate 200 mg for skin infection", "tedizolid phosphate 200 mg once daily tablet", "tedizolid phosphate 200 mg tablet working" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6863dbebfa62312b851d2551", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "oseltamivir phosphate oral suspension", "description": "OSELTATERIS Oral Suspension is a powerful antiviral medication formulated with Oseltamivir Phosphate at a strength of 12 mg/ml, designed for pediatric and adult use. Manufactured under strict quality standards, this oral suspension is used to prevent and treat infections caused by the flu virus, specifically influenza A and B. It works by stopping the spread of the flu virus in the body, reducing the severity and duration of symptoms. OSELTATERIS is especially effective when administered within the first 48 hours of symptom onset.\n\nWhat is Oseltamivir Phosphate Oral Suspension IP 12 mg?\nOseltamivir Phosphate Oral Suspension IP 12 mg is an antiviral medication belonging to the class of neuraminidase inhibitors. This oral formulation is primarily used to prevent and treat flu infections, including seasonal outbreaks and pandemics. The suspension is easy to administer and is typically prescribed for infants, children, or adults who are unable to swallow capsules.\n\nUses of Oseltamivir Phosphate Oral Suspension IP 12 mg/ml\nOSELTATERIS is recommended for the following uses:\n\nTreatment of influenza A and B infections in individuals aged 2 weeks and older\n\nPrevention of influenza in individuals exposed to flu-infected patients or during community outbreaks\n\nReduces flu-related complications such as bronchitis, pneumonia, and ear infections\n\nShortens the duration of symptoms like fever, cough, sore throat, fatigue, and body aches\n\nPrevents and treats infections caused by the flu virus\n\nPossible Side Effects\nLike any medication, oseltamivir phosphate oral suspension IP 12 mg may cause side effects, ranging from mild to serious. Most side effects are temporary and manageable:\n\nCommon side effects include:\n\nNausea\n\nVomiting\n\nAbdominal pain\n\nHeadache\n\nDizziness\n\nLess common or serious side effects include:\n\nSkin rashes or allergic reactions\n\nHallucinations, confusion, or abnormal behavior (especially in children)\n\nSeizures (rare)\n\nSevere vomiting or dehydration\n\nSwelling of the face, lips, or throat\n\nSeek immediate medical attention if any severe allergic reactions or behavioral changes occur.\n\nPrecautions Before Using\nBefore taking OSELTATERIS, consider the following precautions:\n\nInform your doctor if you are allergic to Oseltamivir or any other antiviral drugs\n\nDisclose any history of kidney disease, heart conditions, or chronic respiratory illness\n\nIf pregnant or breastfeeding, consult your healthcare provider before use\n\nDo not use this medication for viral infections other than influenza\n\nComplete the full course even if symptoms improve early to prevent resistance\n\nUse the exact dose prescribed; do not double up on missed doses\n\nDrug Interactions\nOseltamivir may interact with other medications, which can affect its efficacy or increase the risk of side effects.\n\nWhat drugs interact with Oseltamivir Phosphate Oral Suspension IP 12 mg?\n\nLive attenuated influenza vaccine (nasal flu vaccine): Avoid taking oseltamivir 2 weeks before or 48 hours after receiving the nasal flu vaccine, as it may interfere with the vaccine's effectiveness\n\nProbenecid: May increase oseltamivir levels in the body, leading to enhanced effects or toxicity\n\nMethotrexate or Cyclophosphamide: Increased risk of side effects when used concurrently\n\nAnticoagulants (e.g., warfarin): Monitor closely due to possible changes in clotting times\n\nAlways inform your doctor about any vitamins, herbal supplements, or over-the-counter medicines you are using\n\nConclusion\nOSELTATERIS Oral Suspension is a trusted antiviral solution for both prevention and treatment of influenza infections. With the active ingredient oseltamivir phosphate oral suspension IP 12 mg/ml, it effectively reduces the flu’s severity and duration while minimizing the risk of complications. Its child-friendly liquid formulation makes it a reliable choice for families during flu season. Always use under medical supervision for best results and safety.", "price": 788.0, "discountamount": 551.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "48 hours", "prevent resistance", "flus severity", "influenza complete", "precautions inform", "older prevention", "oral suspension", "influenza infections", "medical supervision", "reliable choice", "effectively reduces", "overthecounter medicines", "clotting times", "concurrently anticoagulants", "toxicity methotrexate", "drugs interact", "healthcare provider", "breastfeeding consult", "taking oseltateris", "occur precautions", "medical attention", "throat seek", "face lips", "dehydration swelling", "abnormal behavior", "skin rashes", "bronchitis pneumonia", "fluinfected patients", "individuals exposed", "swallow capsules", "infants children", "seasonal outbreaks", "oral formulation", "neuraminidase inhibitors", "symptom onset", "symptoms oseltateris", "12 mgml designed", "oseltamivir phosphate", "enhanced effects", "side effects", "body leading", "body reducing", "flu season", "flu virus", "viral infections", "typically prescribed", "increase oseltamivir levels", "side effects ranging", "cyclophosphamide increased risk", "treat flu infections", "symptoms improve early", "severe allergic reactions", "antiviral medication belonging", "body aches prevents", "nasal flu vaccine", "treats infections caused", "ear infections shortens", "treat infections caused", "exact dose prescribed", "antiviral drugs disclose", "trusted antiviral solution", "vitamins herbal supplements", "vaccines effectiveness probenecid", "chronic respiratory illness", "strict quality standards" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2141, "imageuri": "https://productimages.withfloats.com/actual/69183d18b651fab4a13f991f.png", "tileimageuri": "https://productimages.withfloats.com/tile/69183d18b651fab4a13f991f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-01T13:00:27.331Z", "updatedon": "2026-03-12T07:33:27.409Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//oseltamivir-phosphate-oral-suspension/2141", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OSELTATERIS ORAL SUSPENSION", "category": "PEDIATRICS", "tags": [ "oseltamivir phosphate oral suspension use", "oseltamivir phosphate oral suspension dosage", "oseltamivir phosphate oral suspension for children", "oseltamivir phosphate oral suspension for flu treatment", "oseltamivir phosphate oral suspension side effects", "oseltamivir phosphate oral suspension price in india", "oseltamivir phosphate oral suspension composition", "oseltamivir phosphate oral suspension pediatric dose", "oseltamivir phosphate oral suspension how to use", "oseltamivir phosphate oral suspension antiviral medicine", "oseltamivir phosphate oral suspension for infants", "oseltamivir oral suspension for kids dosage", "oseltamivir phosphate syrup for children flu", "oseltamivir phosphate oral suspension pediatric uses", "oseltamivir suspension dose by weight", "oseltamivir phosphate oral suspension safety in children", "oseltamivir phosphate oral suspension for influenza", "oseltamivir oral suspension for swine flu", "oseltamivir phosphate oral suspension for viral fever", "oseltamivir phosphate oral suspension vs capsule", "oseltamivir phosphate syrup substitute", "oseltamivir phosphate syrup substitute", "what is oseltamivir phosphate oral suspension used for", "how does oseltamivir phosphate oral suspension work", "when to give oseltamivir oral suspension to child", "can oseltamivir oral suspension be taken with food", "how long does oseltamivir oral suspension take to work" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "67c98ea29006a7b5368cb903", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sucroferric Oxyhydroxide 2500 mg", "description": "RUDIX SUCRO FE contains Sucroferric Oxyhydroxide (2500 mg), a highly effective phosphate binder used in the management of chronic kidney disease (CKD) patients undergoing dialysis. It helps control high phosphate levels (hyperphosphatemia) in the blood, reducing the risk of bone disorders, cardiovascular complications, and other phosphate-related issues. Its iron-based composition ensures efficient phosphate binding while minimizing gastrointestinal side effects.\n\n \nKey Benefits:\n \n\n Effectively Lowers Phosphate Levels – Reduces phosphate absorption in CKD patients on dialysis.\n Prevents Bone & Heart Complications – Protects against renal osteodystrophy and vascular calcification.\n Iron-Based, Non-Calcium Formula – Minimizes the risk of hypercalcemia and calcium overload.\n Fast-Acting & Well-Tolerated – Begins working quickly and causes fewer gastrointestinal issues compared to other phosphate binders.\n Convenient Dosage & Administration – Requires fewer tablets per day, enhancing patient adherence.\n Supports Overall Kidney Health – Helps manage phosphorus balance, improving long-term health outcomes in CKD patients.\n\n \nHow Does It Work?\n \n\nSucroferric Oxyhydroxide acts as a phosphate binder, meaning it binds to dietary phosphate in the intestines and prevents its absorption into the bloodstream. Instead, the bound phosphate is excreted through the stool, effectively lowering serum phosphate levels. This helps protect the bones, heart, and blood vessels from damage caused by excess phosphorus accumulation.\n\n \nDirections for Use:\n \n\nTake as prescribed by a healthcare professional.\nThe usual recommended dose is 1 tablet with each meal, but the dose may be adjusted based on phosphate levels.\nSwallow the tablet whole or chew it before swallowing.\nAvoid taking it with other medications, as it may interfere with their absorption.\nRegular monitoring of phosphate levels is essential to adjust the dosage accordingly.\n \nSide Effects:\n \n\nWhile RUDIX SUCRO FE is generally well-tolerated, some possible side effects include:\n\nMild gastrointestinal issues (diarrhea, nausea, constipation)\nDark-colored stools due to iron content (this is harmless)\nMetallic taste or changes in taste perception\nRare allergic reactions (rash, itching, swelling)\nIf severe symptoms such as persistent stomach pain, vomiting, or difficulty breathing occur, seek immediate medical attention.", "price": 320.0, "discountamount": 96.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "1 tablet", "medical attention", "severe symptoms", "iron content", "generally welltolerated", "side effects", "adjusted based", "healthcare professional", "damage caused", "blood vessels", "bones heart", "helps protect", "renal osteodystrophy", "ckd patients", "phosphaterelated issues", "blood reducing", "bound phosphate", "dietary phosphate", "phosphate levels", "phosphate levels swallow", "absorption regular monitoring", "usual recommended dose", "phosphate binder meaning", "harmless metallic taste", "rudix sucro fe", "swallowing avoid taking" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2066, "imageuri": "https://productimages.withfloats.com/actual/67c98ec0bf545f60b10e551d.png", "tileimageuri": "https://productimages.withfloats.com/tile/67c98ec0bf545f60b10e551d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-03-06T12:01:38.223Z", "updatedon": "2026-03-12T12:13:45.487Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sucroferric-oxyhydroxide-2500-mg/2066", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Steris Healthcare Pvt Ltd", "category": "NEPHROLOGYRANGE", "tags": [ "Sucroferric oxyhydroxide tablet chewable 500 mg", "Sucroferric Oxyhydroxide chewable tablets uses in hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662a161e69b8516f884d214", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SAVELINER 800 ", "description": "SAVELINER 800 \nSevelamer (800mg)\nSaveliner 800 is a medication containing Sevelamer in a strength of 800mg per dose. Sevelamer is a phosphate binder used to treat high levels of phosphate in the blood, commonly seen in patients with chronic kidney disease (CKD) or those undergoing dialysis.\n\nSevelamer works by binding to phosphate from food in the digestive tract, preventing its absorption into the bloodstream. This helps to lower phosphate levels in the blood, reducing the risk of complications such as bone problems and cardiovascular issues associated with high phosphate levels.\n\nIt is typically prescribed by healthcare providers as part of a comprehensive treatment plan for managing CKD and maintaining optimal phosphate levels in the body. Saveliner 800 should be taken as directed by your healthcare provider, usually with meals and accompanied by sufficient water intake.\n\nAs with any medication, there may be possible side effects or interactions with other drugs, so it's important to follow your healthcare provider's instructions closely and report any unusual symptoms or concerns while taking Saveliner 800.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\nhttps://www.sterisonline.com/product/saveliner-800-133675\n\n\n\n\n\n\n", "price": 329.0, "discountamount": 99.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "CKD", "dose", "risk", "food", "part", "body", "meals", "800mg", "Order", "Email", "blood", "patients", "concerns", "dialysis", "WhatsApp", "strength", "SAVELINER", "Sevelamer", "absorption", "medication", "high levels", "information", "other drugs", "interactions", "instructions", "sterispharma", "sterisonline", "complications", "bone problems", "digestive tract", "phosphate binder", "unusual symptoms", "healthcare providers", "cardiovascular issues", "high phosphate levels", "possible side effects", "chronic kidney disease", "sufficient water intake", "optimal phosphate levels", "comprehensive treatment plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1486, "imageuri": "https://productimages.withfloats.com/actual/6662a164a55cd3efef25a4b9.png", "tileimageuri": "https://productimages.withfloats.com/tile/6662a164a55cd3efef25a4b9.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T05:57:53.144Z", "updatedon": "2026-03-12T12:48:18.179Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//saveliner-800-/1486", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAVELINER 800 ", "category": "NEPHROLOGYRANGE", "tags": [ "SAVELINER 800", "Sevelamer (800mg)", "Sevelamer 800mg price", "Sevelamer 800mg uses", "Sevelamer 800 MG Tablet Uses in Hindi", "Sevelamer 800mg dosage", "Sevelamer 800mg generic Name", "Sevelamer 400" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661ae3c4515df17486227d4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SAVELINER 400", "description": "SAVELINER 400\nSevelamer (400mg)\nSaveliner 400 is a medication containing 400mg of Sevelamer, a phosphate binder used in the management of high phosphate levels in patients with chronic kidney disease (CKD). Here are key points about Saveliner 400:\n\nPhosphate Binding: Sevelamer works by binding phosphate in the food you eat, reducing its absorption in the intestine. This helps lower phosphate levels in the blood.\n\nCKD Management: Saveliner 400 is particularly beneficial for patients with CKD, where high phosphate levels can lead to complications like bone disease and cardiovascular issues.\n\nDosage: The typical dosage of Saveliner 400 is determined by your healthcare provider based on your phosphate levels. It's usually taken with meals.\n\nEffectiveness: By lowering phosphate levels, Saveliner 400 helps in preventing mineral and bone disorders often associated with CKD.\n\nConsiderations: It's important to take Saveliner 400 as prescribed and to follow a phosphate-controlled diet as recommended by your doctor for optimal management of CKD.\n\nSide Effects: Common side effects may include nausea, vomiting, diarrhea, or constipation. Inform your doctor if these persist or worsen.\n\nAlways consult your healthcare provider for personalized advice and guidance regarding the use of Saveliner 400.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/saveliner-400-133674", "price": 199.0, "discountamount": 60.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "food", "CKD.", "Email", "400mg", "blood", "meals", "doctor", "nausea", "mineral", "WhatsApp", "patients", "vomiting", "diarrhea", "guidance", "SAVELINER", "Sevelamer", "intestine", "key points", "medication", "absorption", "information", "constipation", "sterispharma", "sterisonline", "bone disease", "complications", "Effectiveness", "typical dosage", "Considerations", "bone disorders", "CKD Management", "phosphate binder", "Phosphate Binding", "optimal management", "Common side effects", "healthcare provider", "personalized advice", "high phosphate levels", "cardiovascular issues", "chronic kidney disease", "phosphate-controlled diet" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1482, "imageuri": "https://productimages.withfloats.com/actual/6661ae400d2c64b6857a9a26.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661ae400d2c64b6857a9a26.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:40:28.702Z", "updatedon": "2026-03-17T07:33:39.955Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//saveliner-400/1482", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAVELINER 400", "category": "NEPHROLOGYRANGE", "tags": [ "SAVELINER 400", "Sevelamer (400mg)", "Sevelamer 400 mg Tablet price", "Sevelamer 400 mg uses", "Sevelamer Carbonate Tablets 400 mg", "Sevelamer 400 Mg Tablet Uses in Hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661aa55e5c8fb18fc1957bd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PHOSACETATE", "description": "PHOSACETATE\nCalcium Acetate 667mg\nPhosacetate is a medication containing Calcium Acetate 667mg, used to manage high phosphate levels in individuals with kidney disease. It works by binding to dietary phosphate in the digestive tract, preventing its absorption into the bloodstream.\n\nKey Information:\n\nActive Ingredient: Each tablet contains Calcium Acetate 667mg.\nUses: Phosacetate is prescribed to lower elevated phosphate levels in patients undergoing dialysis due to chronic kidney disease.\nDosage: The typical dosage is determined by the healthcare provider based on the patient's phosphate levels and response to treatment.\nAdministration: Take Phosacetate orally with meals or as directed by the physician.\nSide Effects: Common side effects may include constipation, nausea, vomiting, diarrhea, or stomach discomfort.\nPrecautions: Inform your doctor about any allergies or medical conditions before starting Phosacetate. Monitor calcium levels regularly during treatment.\nPrice: Prices may vary depending on the brand and dosage strength. Consult with your pharmacist for specific pricing information.\nConclusion: Phosacetate is an effective medication for managing high phosphate levels in individuals with kidney disease, helping to improve overall health and quality of life.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/phosacetate-133672\n\n\n\n\n\n", "price": 125.0, "discountamount": 38.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "life", "Uses", "meals", "Email", "ORDER", "brand", "Price", "tablet", "doctor", "nausea", "quality", "response", "dialysis", "vomiting", "WhatsApp", "diarrhea", "patients", "treatment", "physician", "allergies", "absorption", "pharmacist", "Conclusion", "Precautions", "PHOSACETATE", "individuals", "bloodstream", "constipation", "sterispharma", "sterisonline", "typical dosage", "overall health", "Administration", "calcium levels", "digestive tract", "dosage strength", "Key Information", "Calcium Acetate", "Active Ingredient", "dietary phosphate", "medical conditions", "stomach discomfort", "healthcare provider", "Common side effects", "effective medication", "high phosphate levels", "chronic kidney disease", "elevated phosphate levels", "specific pricing information" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1477, "imageuri": "https://productimages.withfloats.com/actual/6661aa57c749b7962dbc2c75.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661aa57c749b7962dbc2c75.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:23:49.277Z", "updatedon": "2026-03-12T12:39:45.805Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//phosacetate/1477", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PHOSACETATE", "category": "NEPHROLOGYRANGE", "tags": [ "PHOSACETATE", "Calcium Acetate 667mg", "Calcium acetate 667 mg uses", "Calcium acetate 667 mg brand Name", "Calcium acetate 667 mg dosage", "Calcium acetate side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661a73687f0960e14a2c739", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "mycophenolate sodium 360 mg", "description": "MYCOPLASM S 360 \nMycophenolate sodium 360 mg is an essential immunosuppressant medication designed to prevent organ transplant rejection, particularly for kidney, heart, and liver transplants. As the sodium salt of mycophenolic acid, it delivers 360 mg of the active moiety per tablet, providing targeted immune suppression to help patients maintain their new organs long-term. This product stands out for its enteric-coated formulation, which enhances gastrointestinal tolerability compared to other forms, making it a preferred choice in post-transplant care regimens.​\n\nUses of Mycophenolate Sodium 360 mg\nMycophenolate sodium 360 mg primarily serves as a prophylactic agent against acute rejection in adult and pediatric patients receiving allogeneic renal, cardiac, or hepatic transplants. It works alongside other immunosuppressants like cyclosporine and corticosteroids to create a balanced regimen that minimizes the risk of graft loss. Clinically, it proves effective in de novo transplant recipients, where starting therapy early post-surgery significantly reduces rejection episodes. Beyond transplants, off-label applications include managing refractory autoimmune conditions such as lupus nephritis or myasthenia gravis, where immune overactivity damages tissues.​\n\nThe drug targets the proliferation of T- and B-lymphocytes, key players in immune responses that can attack transplanted organs. In renal transplant patients, for instance, it helps preserve kidney function by curbing antibody-mediated rejection. Its role extends to maintenance therapy, where consistent dosing sustains immunosuppression without excessive toxicity. Healthcare providers often adjust it based on patient response and trough levels of the active metabolite, mycophenolic acid (MPA), ensuring optimal therapeutic outcomes.​\n\nKey Benefits of Mycophenolate Sodium 360 mg\nMycophenolate sodium 360 mg offers several advantages that make it a cornerstone in transplant medicine. One primary benefit is its selective inhibition of lymphocyte proliferation, sparing other cell types and reducing broad-spectrum immunosuppression risks. This leads to fewer opportunistic infections compared to older agents like azathioprine. The enteric coating minimizes upper GI upset, improving patient compliance—studies show higher adherence rates with this formulation.​\n\nEnhanced Graft Survival: Prolongs organ viability by effectively suppressing cell-mediated and humoral immunity, with clinical data showing reduced biopsy-proven rejection rates.\n\nImproved Tolerability: Lower incidence of nausea and diarrhea due to delayed-release technology, allowing twice-daily dosing without food restrictions.\n\nFlexible Dosing: Equivalent to 720 mg mycophenolate mofetil, but with predictable MPA exposure via enterohepatic recirculation for steady-state efficacy.\n\nPediatric Suitability: Approved for children over 2 years in renal transplants, supporting growth without compromising safety.\n\nCost-Effective Long-Term Option: Balances efficacy and side effect profile, potentially lowering overall healthcare costs from fewer rejections or hospitalizations.​\n\nPatients experience better quality of life, with sustained energy levels and fewer interruptions from acute rejection crises. Its metabolism to MPA via liver glucuronidation ensures reliable pharmacokinetics, even in patients with mild renal impairment.​\n\nSide Effects of Mycophenolate Sodium 360 mg\nWhile highly effective, mycophenolate sodium 360 mg carries risks typical of immunosuppressants, necessitating vigilant monitoring. Common adverse effects stem from its impact on rapidly dividing cells, particularly in the gut and bone marrow.\n\nCommon Side Effects\nGastrointestinal issues like diarrhea, nausea, vomiting, and abdominal pain, affecting up to 30-50% of users.\n\nHeadache, insomnia, and tremor, often mild and transient.\n\nInfections such as urinary tract or respiratory, due to moderated immunity.\n\nHypertension or peripheral edema, manageable with supportive care.\n\nLeukopenia or anemia, requiring periodic blood counts.​\n\nSerious Side Effects\nSevere myelosuppression leading to neutropenia or thrombocytopenia, which can increase infection or bleeding risks.\n\nProgressive multifocal leukoencephalopathy (PML), a rare brain infection linked to JC virus reactivation.\n\nGastrointestinal perforation or bleeding, especially in at-risk patients.\n\nIncreased malignancy risk, including lymphoma or skin cancers, over long-term use.\n\nHypersensitivity reactions like rash or anaphylaxis.​\n\nRegular complete blood counts, viral monitoring (e.g., CMV, BK virus), and skin exams mitigate these risks. Dose reductions or discontinuation may be needed if counts drop significantly.​\n\nMechanism of Action\nMycophenolate sodium 360 mg rapidly hydrolyzes to mycophenolic acid (MPA), a potent, reversible, non-competitive inhibitor of inosine-5'-monophosphate dehydrogenase (IMPDH). This enzyme catalyzes the rate-limiting step in de novo guanine nucleotide synthesis, depleting guanosine nucleotides essential for T- and B-cell DNA replication. Lymphocytes, reliant on this pathway, undergo proliferation arrest, suppressing both cell-mediated immunity and antibody production.​\n\nMPA also hinders glycosylation of adhesion molecules on lymphocytes and monocytes, impeding their migration to graft sites. It reduces nitric oxide production in macrophages without affecting endothelial cells, curbing inflammation. Enterohepatic recirculation of the glucuronide metabolite (MPAG) prolongs MPA exposure, enhancing efficacy. Protein binding to albumin (around 97%) ensures targeted delivery, with clearance primarily renal for the inactive form.​\n\nDosage and Administration Guidelines\nStandard dosing for renal transplant is 720 mg (two 360 mg tablets) twice daily, starting within 72 hours post-surgery. Adjustments occur for hepatic or cardiac transplants, often alongside cyclosporine. Therapeutic drug monitoring of MPA AUC (area under curve) optimizes levels between 30-60 mcg·h/mL. Take on an empty stomach for best absorption, though food has minimal impact due to the coating.​\n\nPrecautions and Warnings\nAvoid in pregnancy (Category D) due to teratogenicity—use contraception and regular pregnancy tests. Contraindicated in active untreated infections. Monitor for GI bleeding in ulcerative colitis patients. Drug interactions with antacids, cholestyramine, or rifampin alter MPA levels. Live vaccines are prohibited.​\n\nConclusion\nMycophenolate sodium 360 mg represents a vital advancement in transplant immunosuppression, offering robust protection against rejection with a favorable benefit-risk profile. Its targeted action on lymphocytes, combined with improved GI tolerance, empowers patients to thrive post-transplant. By integrating it into comprehensive regimens with close monitoring, healthcare teams maximize graft success and patient well-being. Always consult a specialist for personalized guidance to harness its full potential safely.\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/mycoplasm-s-360-133670\n\n\n\n\n\n\n", "price": 767.0, "discountamount": 567.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "dose", "risk", "body", "part", "ORDER", "360mg", "Email", "cells", "dosage", "nausea", "vomiting", "schedule", "headache", "strength", "WhatsApp", "diarrhea", "activity", "rejection", "treatment", "infections", "supplements", "information", "MYCOPLASM S", "sterispharma", "sterisonline", "stomach pain", "blood counts", "immune system", "complications", "liver problems", "liver function", "other medications", "Regular monitoring", "medical conditions", "healthcare provider", "Common side effects", "Serious side effects", "white blood cell count", "potential drug interactions", "optimal therapeutic effects", "combination therapy regimen", "organ transplant recipients", "Mycophenolate Sodium therapy", "other immunosuppressive drugs" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1474, "imageuri": "https://productimages.withfloats.com/actual/6661a739c749b7962dbc08c6.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661a739c749b7962dbc08c6.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:10:30.488Z", "updatedon": "2026-03-12T08:02:36.733Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mycophenolate-sodium-360-mg/1474", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOPLASM S 360 ", "category": "Oncology", "tags": [ "MYCOPLASM S 360", "Mycophenolate sodium (360mg)", "Mycophenolate sodium 360 mg price", "Mycophenolate sodium 360 mg brands", "Mycophenolate sodium 360 mg side effects", "Myfortic 360 alternative", "Myfortic 500" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a50a78a75263abd944f583a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Loteprednol Etabonate Ophthalmic Suspension", "description": "Loteprednol etabonate ophthalmic suspension is a prescription corticosteroid eye drop used to treat steroid-responsive inflammatory conditions of the eye, including post-surgical inflammation, allergic conjunctivitis, and certain forms of anterior uveitis. What sets loteprednol apart from older ophthalmic steroids is its “ester-based” chemical structure, which is designed to break down into inactive components after acting on eye tissue — giving it a comparatively lower risk of raising intraocular pressure (IOP) than traditional steroids like prednisolone or dexamethasone, while still delivering effective anti-inflammatory action. The typical dose is one to two drops in the affected eye, four times daily, or as directed, usually for a short, defined course rather than indefinite use. Common side effects include burning, stinging, and blurred vision, while prolonged or unsupervised use can still carry steroid-related risks such as elevated eye pressure. It is a Schedule H prescription-only medicine in India.\n\nWhat Is Loteprednol Etabonate Ophthalmic Suspension?\nLoteprednol etabonate ophthalmic suspension is a topical corticosteroid formulated specifically for use in the eye. It belongs to a category sometimes referred to as “site-specific” or “soft” steroids — a design approach where the drug is engineered to be highly active at the site of application (the eye) but rapidly metabolized into inactive by-products once it has acted, reducing the potential for the cumulative steroid-related side effects seen with older ophthalmic corticosteroids.\nThis suspension is commonly prescribed for:\n\nManaging inflammation following eye surgery, such as cataract surgery\nTreating allergic conjunctivitis, including seasonal allergic conjunctivitis\nCertain anterior segment inflammatory conditions, such as uveitis, under specialist supervision\nGiant papillary conjunctivitis and other steroid-responsive ocular surface conditions\n\nBecause of its comparatively favorable IOP profile, loteprednol is often considered by ophthalmologists for patients who need effective anti-inflammatory therapy but may be at higher risk from more potent steroids — though it is important to note that no ophthalmic steroid is entirely free of IOP-related risk, and monitoring remains necessary.\n\nHow Does Loteprednol Etabonate Work? (Mechanism of Action)\n\nCorticosteroid receptor binding – Loteprednol etabonate binds to glucocorticoid receptors within ocular tissue, initiating anti-inflammatory gene expression changes.\nSuppression of inflammatory mediators – This binding reduces the production of key inflammatory substances, including prostaglandins and cytokines, that drive redness, swelling, and discomfort.\nReduced vascular permeability – By calming the inflammatory cascade, the drug helps reduce leakage of fluid and inflammatory cells into ocular tissue, easing swelling.\nEster-based metabolism – Unlike ketone-based steroids, loteprednol's ester structure allows ocular esterases to break it down into inactive metabolites after it exerts its effect, which is thought to underlie its comparatively lower propensity to raise intraocular pressure.\nLocalized anti-inflammatory effect – The net result is effective control of ocular surface and anterior segment inflammation with a more favorable safety profile than some older steroid formulations, when used for the intended short duration.\n\n\nClinical Indications\nIndicationDetailsPost-operative ocular inflammationCommon after cataract and other intraocular surgeriesAllergic conjunctivitisIncluding seasonal allergic conjunctivitisGiant papillary conjunctivitisOften associated with contact lens wearAnterior uveitisUnder specialist supervisionOther steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segmentAs directed by an ophthalmologist\nNot indicated for: viral (e.g., herpes simplex), fungal, or mycobacterial eye infections, where corticosteroid use can worsen the underlying condition.\n\nDosage & Administration\nParameterRecommendationStandard dose1–2 drops in the affected eye(s), typically 4 times dailyPost-surgical regimenOften started at higher frequency and tapered per surgeon's protocolShake before useYes — this is a suspension; shake well before each applicationDurationShort, defined course as prescribed; not intended for indefinite useTaperingGradual reduction recommended rather than abrupt discontinuation after extended useContact lensesRemove before instillation; reinsert only per your doctor's adviceMissed doseApply as soon as remembered; do not double the next dose\nImportant: Even with its comparatively favorable safety profile, loteprednol should be used strictly for the duration prescribed. Extended, unsupervised use is not recommended.\n\nKey Benefits\n\nEffective anti-inflammatory action for a range of steroid-responsive ocular conditions\nEster-based design associated with a comparatively lower risk of raising intraocular pressure than some older ophthalmic steroids\nUseful for patients needing steroid therapy who may be more sensitive to IOP elevation, under appropriate monitoring\nSuitable for both post-surgical inflammation control and allergic conjunctivitis management\nAvailable in a suspension formulation designed for good ocular surface contact\nOften used as part of a short, defined treatment course, reducing exposure duration compared to continuous long-term steroid regimens\n\n\nPrecautions\n\nUse strictly under ophthalmologist supervision — this is not an over-the-counter product\nNot suitable for viral, fungal, or mycobacterial eye infections\nEven with its favorable profile, prolonged use can still raise intraocular pressure in susceptible individuals — periodic IOP monitoring is recommended\nExtended use may increase the risk of cataract formation, as with other ophthalmic steroids\nMay mask signs of infection or delay wound healing if used inappropriately\nInform your doctor of any history of glaucoma, herpes eye infection, or corneal thinning before starting\nShake the suspension well before each use for accurate dosing\nAvoid touching the dropper tip to the eye or any surface\n\n\nSide Effects\nCommon (Usually Mild and Temporary)\n\nBurning or stinging sensation on instillation\nBlurred vision immediately after application\nEye discomfort or a foreign-body sensation\nMild eye redness\n\nLess Common / Serious (Consult Your Doctor Promptly)\n\nElevated intraocular pressure (comparatively less frequent than with older steroids, but still possible)\nDelayed wound healing\nSigns of secondary or masked ocular infection\nCataract progression with prolonged use\nAllergic reaction (eyelid swelling, itching, rash)\n\nDiscontinue and consult your ophthalmologist promptly if any serious symptom develops.\n\nComparison: Loteprednol vs. Other Ophthalmic Corticosteroids\nTreatmentClassIOP Risk ProfileBest Suited ForLoteprednol etabonate suspensionEster-based (“soft”) corticosteroidComparatively lowerPatients needing effective anti-inflammatory action with reduced IOP concernPrednisolone acetateKetone-based corticosteroidHigher with prolonged useRobust anti-inflammatory action; requires closer IOP monitoringDexamethasoneKetone-based corticosteroidHigher, potent effectSevere inflammatory conditions; typically shorter coursesFluorometholoneKetone-based corticosteroidModerateMild to moderate inflammation with somewhat reduced IOP risk\n\nKey Statistics (Placeholder — Pending Clinical Reviewer Verification)\nMetricValueReported incidence of clinically significant IOP elevation with short-course loteprednol use[Placeholder – insert verified clinical trial statistic]Comparative IOP-elevation rate vs. prednisolone acetate in controlled studies[Placeholder – insert verified reference]Typical duration of post-operative loteprednol therapy[Placeholder – insert reference range]\nAll statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication.\n\nExpert Insight\n\n[Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.]\n\n\nPrice of Loteprednol Etabonate Ophthalmic Suspension\nThe price of loteprednol etabonate ophthalmic suspension varies depending on brand, pack size, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or an authorized pharmacy.\nPrescription only – consult your doctor.\n\nConclusion\nLoteprednol etabonate ophthalmic suspension offers a valuable option for managing steroid-responsive ocular inflammation — from post-surgical recovery to allergic conjunctivitis — with a design intended to reduce the intraocular pressure risks historically associated with ophthalmic corticosteroids. While its ester-based structure gives it a comparatively favorable safety profile, it remains a steroid, and prolonged or unsupervised use can still carry risks such as elevated eye pressure, cataract progression, and delayed healing. For this reason, loteprednol should always be used for the specific duration prescribed, with appropriate tapering and regular ophthalmic follow-up, rather than as a long-term, self-managed therapy.\n\nFrequently Asked Questions\n\n1. What is loteprednol etabonate ophthalmic suspension used for?\nIt is used to treat steroid-responsive eye inflammation, including inflammation after eye surgery, allergic conjunctivitis, and certain anterior segment inflammatory conditions such as uveitis, under an ophthalmologist's guidance.\n\n2. Is loteprednol a steroid?\nYes, loteprednol etabonate is a corticosteroid. It is specifically designed with an ester-based structure intended to reduce the risk of raising intraocular pressure compared to some older ophthalmic steroids, though it still requires medical supervision.\n\n3. How long can I use loteprednol eye drops?\nLoteprednol is typically prescribed for a short, defined course as determined by your ophthalmologist, often with a tapering schedule. It is not intended for indefinite, unsupervised long-term use.\n\n4. Does loteprednol raise eye pressure?\nLoteprednol has a comparatively lower risk of raising intraocular pressure than some older ophthalmic steroids due to its ester-based design, but it can still cause elevated eye pressure in susceptible individuals, especially with prolonged use, so periodic monitoring is recommended.\n\n5. Can loteprednol cause cataracts?\nProlonged use of any ophthalmic corticosteroid, including loteprednol, can increase the risk of cataract formation, particularly posterior subcapsular cataracts, which is why short, supervised courses are recommended.\n\n6. How is loteprednol different from prednisolone acetate?\nLoteprednol has an ester-based chemical structure designed to break down into inactive components after acting on the eye, which is associated with a lower risk of raising intraocular pressure compared to prednisolone acetate, a ketone-based steroid with a higher IOP-elevation potential.\n\n7. Can loteprednol be used for allergic conjunctivitis?\nYes, loteprednol etabonate ophthalmic suspension is commonly used to manage allergic conjunctivitis, including seasonal allergic conjunctivitis, especially when symptoms are significant or not controlled by other treatments.\n\n8. Is loteprednol safe after cataract surgery?\nYes, loteprednol is frequently prescribed to manage post-operative inflammation following cataract surgery, typically as part of a tapering regimen directed by the operating ophthalmologist.\n\n9. Can loteprednol be used for viral eye infections?\nNo, loteprednol and other corticosteroids are not appropriate for viral eye infections such as herpes simplex keratitis, as steroids can worsen these conditions if used inappropriately.\n\n10. What are the common side effects of loteprednol eye drops?\nCommon side effects include burning or stinging upon application, temporary blurred vision, mild eye redness, and eye discomfort. These are usually mild and resolve quickly.\n11. Does loteprednol need to be shaken before use?\nYes, since it is a suspension, the bottle should be shaken well before each use to ensure the medication is evenly distributed.\n\n12. Can loteprednol be stopped suddenly?\nStopping abruptly, especially after extended use, is generally not recommended. A gradual tapering schedule, as advised by your ophthalmologist, helps prevent rebound inflammation.\n\n13. Is loteprednol safe for long-term daily use?\nNo, loteprednol is generally intended for short, supervised courses rather than continuous long-term daily use, due to steroid-related risks with prolonged exposure.\n\n14. Can contact lenses be worn while using loteprednol?\nIt's generally recommended to remove contact lenses before applying loteprednol and reinsert them only after the interval advised by your doctor.\n\n15. Who should avoid using loteprednol eye drops?\nPatients with active untreated viral, fungal, or mycobacterial eye infections, or known hypersensitivity to the medication, should avoid loteprednol unless specifically directed otherwise by their ophthalmologist.\n\n16. Can loteprednol be used in children?\nUse in children should only occur under the direct guidance and prescription of a pediatric ophthalmologist, based on individual clinical assessment.\n17. Does loteprednol cause blurred vision?\nTemporary blurred vision can occur immediately after instillation in some patients and usually resolves quickly. Persistent blurred vision should be reported to your doctor.", "price": 150.0, "discountamount": 45.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2471, "imageuri": "https://productimages.withfloats.com/actual/6a50a78cd95cad00a915a6d8.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a50a78cd95cad00a915a6d8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-10T08:04:26.663Z", "updatedon": "2026-07-10T08:04:26.663Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//loteprednol-etabonate-ophthalmic-suspension/2471", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION LOPEDIUM 0.5%", "category": "Opthalmology Range", "tags": [ "Loteprednol Etabonate Ophthalmic Suspension", "loteprednol etabonate ophthalmic suspension uses", "loteprednol etabonate ophthalmic suspension uses in hindi", "loteprednol etabonate ophthalmic suspension in hindi", "loteprednol etabonate ophthalmic suspension eye drops uses", "loteprednol etabonate ophthalmic suspension eye drops", "loteprednol etabonate ophthalmic suspension use" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }

Still searching for
phosphate binding medication for ckd patients?

Still searching for
phosphate binding medication for ckd patients?

Chat with us